Haploinsufficiency of SAMD9L, an Endosome Fusion Facilitator, Causes Myeloid Malignancies in Mice Mimicking Human Diseases with Monosomy 7
Akiko Nagamachi(Hiroshima University), Toshiya Inaba(Hiroshima University), Takuro Nakamura(Tokyo Medical University), Yuko Ozaki(Hiroshima University), Keiyo Takubo(Keio University), Toshio Suda(Chinese Academy of Sciences), Hirotaka Matsui(Hiroshima University), Akinori Kanai(Frontier Medical College), Hiroya Asou(Hiroshima University), Linda Wolff(National Institutes of Health), Hiroaki Honda(Tokyo Women's Medical University), Daisuke Aki(La Jolla Institute for Immunology)
Cited by 156
Related Papers
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
|Proceedings of the National Academy of Sciences|1998|4.3k
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis<i>in Vitro</i><sup>1</sup>
|Endocrinology|1998|1.2k
DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells
|The Journal of Experimental Medicine|2005|899
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
|Cell Metabolism|2006|771
Commitment and Differentiation of Osteoclast Precursor Cells by the Sequential Expression of C-Fms and Receptor Activator of Nuclear Factor κb (Rank) Receptors
|The Journal of Experimental Medicine|1999|694